Does ADAGRASIB Cause Decreased appetite? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Decreased appetite have been filed in association with ADAGRASIB (KRAZATI). This represents 4.8% of all adverse event reports for ADAGRASIB.
43
Reports of Decreased appetite with ADAGRASIB
4.8%
of all ADAGRASIB reports
4
Deaths
20
Hospitalizations
How Dangerous Is Decreased appetite From ADAGRASIB?
Of the 43 reports, 4 (9.3%) resulted in death, 20 (46.5%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ADAGRASIB.
What Other Side Effects Does ADAGRASIB Cause?
Death (272)
Diarrhoea (113)
Hospitalisation (108)
Nausea (87)
Vomiting (79)
Off label use (70)
Asthenia (61)
Fatigue (51)
Dehydration (35)
Dyspnoea (32)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ADAGRASIB Alternatives Have Lower Decreased appetite Risk?
ADAGRASIB vs ADALIMUMAB
ADAGRASIB vs ADALIMUMAB-AACF
ADAGRASIB vs ADALIMUMAB-AATY
ADAGRASIB vs ADALIMUMAB-ADAZ
ADAGRASIB vs ADALIMUMAB-ADBM